Publications by authors named "William Low"

Claim this Profile
T
Tackling physical inactivity and inequalities: implementing a whole systems approach to transform community provision for disabled people and people with long-term health conditions.
Anna Pettican, Robert Southall-Edwards, Gina Yannitell Reinhardt, Valerie Gladwell, Paul Freeman, William Low

BMC Public Health· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins).
Judit Erchegyi, Lixin Wang, Jozsef Gulyas, Manoj Samant, Marilyn H Perrin, William Low

J Med Chem· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin.
Yifeng Xia, Yi-Liang Liu, Yonghua Xie, Wei Zhu, Francisco Guerra, William Low

Sci Transl Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural cells secrete a unique repertoire of proteins.
David Schubert, Federico Herrera, Robert Cumming, Jessica Read, William Low

J Neurochem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.
Judit Erchegyi, Carl A Hoeger, William Low, Daniel Hoyer, Beatrice Waser

J Med Chem· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post-translationally modified conotoxin, reveals that the glycan structure is alpha-D-Gal-(1-->3)-alpha-D-GalNAc.
James Kang, William Low, Thomas Norberg, Jill Meisenhelder, Karin Hansson

Eur J Biochem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MALDI-MS analysis of peptides modified with photolabile arylazido groups.
William Low, James Kang, Michael DiGruccio, Dean Kirby, Marilyn Perrin

J Am Soc Mass Spectrom· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Jean Rivier, Judit Erchegyi, Carl Hoeger, Charleen Miller, William Low

J Med Chem· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis